New Jersey Accutane Mass Tort Gets New Name: Accutane MCL
Tracy Ray | September 2nd, 2012
The New Jersey Accutane mass tort will henceforth be known as the Accutane multicounty litigation, or MCL. The name change follows the New Jersey Supreme Court’s July 19, 2012 decision to change the name of all mass torts in that state to multicounty litigation. The name change will take effect on Sept. 4, 2012. The new name echoes that of consolidated federal litigation, which is called multidistrict litigation or MDL.
Name change does not affect legal process
The legal process for Accutane litigation in the MCL will remain the same, unaffected by the name change. The goal of MCLs, as with MDLs, is to consolidate lawsuits that involve the same product and defendant, make similar claims, and rely on similar evidence, in order to streamline the legal process, avoid duplicate discovery, and prevent the possibility of conflicting rulings by different judges. A transfer of a lawsuit to the MCL can be requested by any lawyer or individual assignment judge, but it is up to the New Jersey Supreme Court to decide whether or not to grant the request.
New Jersey has a number of MCLs involving prescription drugs because a number of large drug companies have their headquarters in that state. In addition to the Accutane MCL, MCLs involving Yaz and Yasmin, Fosamax, and NuvaRing have been established in New Jersey.
Two plaintiffs in Accutane MCL recently awarded 8 million
Two plaintiffs in the Accutane mass tort (which will now be called the Accutane MCL) were recently awarded 8 million in compensation for Accutane injuries suffered by the plaintiffs, Kathleen Rossitto and Riley Wilkinson.
Most lawsuits involving Accutane make similar claims, charging that the drug’s manufacturer, Hoffman-LaRoche, did not adequately warn patients and physicians about potential adverse side effects such as inflammatory bowel disease, which includes ulcerative colitis and Crohns disease from Accutane.
The Accutane MCL is based in the Atlantic County Superior Court in New Jersey and is being overseen by Judge Carol E. Higbee. More than 1,150 cases have joined the Accutane MCL so far in 2012 alone, bringing the total to nearly 8,000 lawsuits.
- Jury Awards 8 Million to Two Plaintiffs in Accutane Mass Tort
- Accutane Litigation Proceeds as Bellwether Trials Are Heard in New Jersey
- Accutane Lawsuit Pulled to Federal Court